You may also like
A Systematic Review and Meta-Analysis of Bivalirudin Application in Peripheral Endovascular Procedures
The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to unfractionated heparin (UFH) in percutaneous coronary interventions for reducing procedural blood loss. The aim of this study was to compare outcome profiles of BIV and UFH in peripheral endovascular procedures (PEPs) by synthesizing the currently available data.
Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure
Background: Progression of heart failure can lead to cardiac transplantation, but when patients are ineligible, long-term mechanical circulatory support may improve survival. […]
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease
Despite ACE2 serving as the portal for infection, the role of ACE inhibitors or angiotensin receptor blockers requires further investigation. COVID-19 poses a challenge for heart transplantation, impacting donor selection, immunosuppression, and post-transplant management.
